Guaifenesin Tablet, Extended Release
Product Images NDC 65162-036

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Guaifenesin (NDC 65162-036). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

600mg Blister (Guaifenesin Extended Release Tablets 1)

Guaifenesin Extended-Release Tablet 600 mg label in a push-through foil blister pack. The label includes the dosage strength and distribution information by Amneal Pharmaceuticals LLC, Bridgewater, NJ. The blister section also highlights a non-varnish area and space for lot number and expiration date.*

FDA Label Image

1200mg 30ct Carton (Guaifenesin Extended Release Tablets 10)

Packaging label for Guaifenesin Extended-Release Tablets 1200 mg by Amneal Pharmaceuticals LLC. The label displays a maximum strength expectorant in an extended-release oral tablet form. The carton includes a depiction of the blue, oval tablet imprinted with 'AN037' and details the package contains 30 tablets. Additional drug facts and directions are shown on the side panels.*

FDA Label Image

1200mg 60ct Label (Guaifenesin Extended Release Tablets 11)

This label panel for Guaifenesin Extended-Release Tablets 1200 mg includes dosing directions, cautioning not to crush, chew, or break the tablet and to take with a full glass of water. It specifies adult and child dosing over 12 years and notes children under 12 should not use. Distributed by Amneal Pharmaceuticals LLC. Also contains product identification and trademark information.*

FDA Label Image

1200mg 60ct Carton (Guaifenesin Extended Release Tablets 12)

The packaging label for Guaifenesin Extended-Release Tablets 1200 mg from Amneal Pharmaceuticals LLC. It is labeled as maximum strength with 60 extended-release tablets. The label features a blue oblong tablet image with imprint AM 037. Drug facts panels detail the active ingredient, purpose, uses, warnings, directions, inactive ingredients, and manufacturer information. The label also includes a barcode and contact information for questions.*

FDA Label Image

600mg Blister Carton (Guaifenesin Extended Release Tablets 2)

Guaifenesin Extended-Release Tablets 600 mg oral tablets packaging label by Amneal Pharmaceuticals LLC. The front displays the product name, strength 600 mg, and 20 extended-release tablets in a 12-hour expectorant form. The label includes drug facts, directions, warnings, inactive ingredients, and distributor information on a white and blue carton with dosage and safety details.*

FDA Label Image

600mg 30ct Label (Guaifenesin Extended Release Tablets 3)

Label for Guaifenesin Extended-Release Tablets 600 mg by Amneal Pharmaceuticals LLC. The label states the product is an expectorant and includes 30 extended-release tablets. Directions advise not to crush, chew, or break tablets and to take with water. The label compares to the active ingredient in Mucinex and includes a barcode and lot and expiration date fields.*

FDA Label Image

600mg 30ct Carton (Guaifenesin Extended Release Tablets 4)

Packaging label for Guaifenesin Extended-Release Tablets 600 mg by Amneal Pharmaceuticals LLC. This over-the-counter oral tablet includes 30 extended-release tablets. The label features the product name, strength, purpose as an expectorant, tablet image, and multiple Drug Facts panels with active ingredients, warnings, directions, inactive ingredients, and distributor information.*

FDA Label Image

600mg 60ct Label (Guaifenesin Extended Release Tablets 5)

Label for Guaifenesin Extended-Release Tablets, 600 mg, an expectorant by Amneal Pharmaceuticals LLC. The label includes dosage form as extended-release tablets, package quantity of 60 tablets, and directions for use. It also features a small image of a blue oblong tablet marked AN036, a barcode, and distributor information from Bridgewater, NJ.*

FDA Label Image

600mg 60ct Carton (Guaifenesin Extended Release Tablets 6)

Guaifenesin Extended-Release Tablets 600 mg expectorant carton label by Amneal Pharmaceuticals LLC. The label includes drug facts, uses, warnings, directions, inactive ingredients, and contact information. The package contains 60 extended-release tablets and highlights relief of chest congestion and mucus thinning.*

FDA Label Image

1200mg Blister (Guaifenesin Extended Release Tablets 7)

Label for Guaifenesin Maximum Strength Extended-Release Tablet 1200 mg distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ. The label repeatedly states the product name and distributor. It includes instructions "PUSH TABLET THROUGH FOIL" and areas for Lot Number and Expiration Date, with a designated non-varnish area.*

FDA Label Image

1200mg Blister Carton (Guaifenesin Extended Release Tablets 8)

Packaging label for Guaifenesin Extended-Release Tablets 1200 mg by Amneal Pharmaceuticals LLC. The label indicates 28 extended-release tablets per package and highlights its use as an expectorant that relieves chest congestion and thins mucus for 12 hours. The label includes drug facts, directions, warnings, inactive ingredients, and contact information.*

FDA Label Image

1200mg 30ct Label (Guaifenesin Extended Release Tablets 9)

Label for Guaifenesin Extended-Release Tablets 1200 mg, an expectorant oral tablet in extended-release form. The label shows 30 tablets per package and is distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ. It includes directions for use and a blue tablet image marked 'AN037'.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.